Q8VHY0 (CSPG4_MOUSE) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 91.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Chondroitin sulfate proteoglycan 4 Alternative name(s): Chondroitin sulfate proteoglycan NG2 Proteoglycan AN2 | ||||
| Gene names |
| ||||
| Organism | Mus musculus (Mouse) [Reference proteome] | ||||
| Taxonomic identifier | 10090 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Glires › Rodentia › Sciurognathi › Muroidea › Muridae › Murinae › Mus › Mus![]() |
Protein attributes
| Sequence length | 2327 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Proteoglycan playing a role in cell proliferation and migration which stimulates endothelial cells motility during microvascular morphogenesis. May also inhibit neurite outgrowth and growth cone collapse during axon regeneration. Cell surface receptor for collagen alpha 2(VI) which may confer cells ability to migrate on that substrate. Binds through its extracellular N-terminus growth factors, extracellular matrix proteases modulating their activity. May regulate MPP16-dependent degradation and invasion of type I collagen participating in melanoma cells invasion properties. May modulate the plasminogen system by enhancing plasminogen activation and inhibiting angiostatin. Functions also as a signal transducing protein by binding through its cytoplasmic C-terminus scaffolding and signaling proteins. May promote retraction fiber formation and cell polarization through Rho GTPase activation. May stimulate alpha-4, beta-1 integrin-mediated adhesion and spreading by recruiting and activating a signaling cascade through CDC42, ACK1 and BCAR1. May activate FAK and ERK1/ERK2 signaling cascades. Ref.6 Ref.7 |
| Subunit structure | Interacts with ITGA4 through its chondroitin sulfate glycosaminoglycan. Interacts with BCAR1, CDC42 and ACK1. Interacts with MMP16. Interacts with the first PDZ domain of MPDZ. Interacts with PRKCA. Interacts with LGALS3 and the integrin composed of ITGB1 and ITGA3. Binds TNC, laminin-1, COL5A1 and COL6A2. Interacts with PLG and angiostatin. Binds FGF2 and PDGFA By similarity. Interacts with GRIP1, GRIP2 and GRIA2. Forms a ternary complex with GRIP1 and GRIA2. Ref.1 |
| Subcellular location | Apical cell membrane; Single-pass type I membrane protein; Extracellular side. Cell projection › lamellipodium membrane; Single-pass type I membrane protein; Extracellular side. Note: Localized at the apical plasma membrane it relocalizes to the lamellipodia of astrocytoma upon phosphorylation by PRKCA. Localizes to the retraction fibers. A fraction may undergo cell surface proteolysis and secretion By similarity. Localizes to the plasma membrane of oligodendrocytes. Ref.1 |
| Tissue specificity | Expressed in microcascular pericytes and not endothelial cells. Ref.7 |
| Post-translational modification | O-glycosylated; contains glycosaminoglycan chondroitin sulfate which are required for proper localization and function in stress fiber formation. Involved in interaction with MMP16 and ITGA4 By similarity. Phosphorylation by PRKCA regulates its subcellular location and function in cell motility By similarity. |
| Disruption phenotype | Mice are unresponsive to PDGF-AA through PDGF-alpha receptor. Ref.6 |
| Miscellaneous | Valuable marker for several incompletely differentiated precursor cells. |
| Sequence similarities | Contains 15 CSPG (NG2) repeats. Contains 2 laminin G-like domains. |
| Sequence caution | The sequence BAC26150.1 differs from that shown. Reason: Frameshift at position 1889. |
Ontologies
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q8VHY0-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q8VHY0-2) The sequence of this isoform differs from the canonical sequence as follows: 1-1666: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 3 (identifier: Q8VHY0-3) The sequence of this isoform differs from the canonical sequence as follows: 1657-1694: NAGNILYEHE...SPPARDLAAT → RASLLSHHTD...ASLDPVPAQG 1695-2327: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||
Molecule processing | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal peptide | 1 – 29 | 29 | Potential | ||||||||
| Chain | 30 – 2327 | 2298 | Chondroitin sulfate proteoglycan 4 | PRO_0000041963 | |||||||
Regions | |||||||||||
| Topological domain | 30 – 2229 | 2200 | Extracellular Potential | ||||||||
| Transmembrane | 2230 – 2250 | 21 | Helical; Potential | ||||||||
| Topological domain | 2251 – 2327 | 77 | Cytoplasmic Potential | ||||||||
| Domain | 30 – 193 | 164 | Laminin G-like 1 | ||||||||
| Domain | 203 – 381 | 179 | Laminin G-like 2 | ||||||||
| Repeat | 431 – 524 | 94 | CSPG 1 | ||||||||
| Repeat | 557 – 644 | 88 | CSPG 2 | ||||||||
| Repeat | 666 – 765 | 100 | CSPG 3 | ||||||||
| Repeat | 793 – 883 | 91 | CSPG 4 | ||||||||
| Repeat | 905 – 994 | 90 | CSPG 5 | ||||||||
| Repeat | 1025 – 1113 | 89 | CSPG 6 | ||||||||
| Repeat | 1133 – 1221 | 89 | CSPG 7 | ||||||||
| Repeat | 1246 – 1342 | 97 | CSPG 8 | ||||||||
| Repeat | 1365 – 1454 | 90 | CSPG 9 | ||||||||
| Repeat | 1481 – 1566 | 86 | CSPG 10 | ||||||||
| Repeat | 1588 – 1684 | 97 | CSPG 11 | ||||||||
| Repeat | 1712 – 1808 | 97 | CSPG 12 | ||||||||
| Repeat | 1840 – 1927 | 88 | CSPG 13 | ||||||||
| Repeat | 1949 – 2034 | 86 | CSPG 14 | ||||||||
| Repeat | 2053 – 2152 | 100 | CSPG 15 | ||||||||
| Region | 30 – 640 | 611 | Globular or compact configuration stabilized by disulfide bonds | ||||||||
| Region | 30 – 640 | 611 | Neurite growth inhibition By similarity | ||||||||
| Region | 575 – 1045 | 471 | Interaction with COL6A2 By similarity | ||||||||
| Region | 632 – 1451 | 820 | Interaction with COL5A1 By similarity | ||||||||
| Region | 1591 – 2226 | 636 | Neurite growth inhibition By similarity | ||||||||
| Region | 1592 – 2226 | 635 | Cysteine-containing | ||||||||
| Motif | 2325 – 2327 | 3 | PDZ-binding | ||||||||
| Compositional bias | 640 – 1591 | 952 | Gly/Ser-rich (glycosaminoglycan attachment domain) | ||||||||
Amino acid modifications | |||||||||||
| Modified residue | 2257 | 1 | Phosphothreonine; by PKC/PRKCA By similarity | ||||||||
| Glycosylation | 130 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 349 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 428 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 686 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 773 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1000 | 1 | O-linked (Xyl...) (chondroitin sulfate) By similarity | ||||||||
| Glycosylation | 1136 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1207 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1369 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 1454 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 1650 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 1914 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2021 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Glycosylation | 2039 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2045 | 1 | N-linked (GlcNAc...) Potential | ||||||||
| Glycosylation | 2080 | 1 | N-linked (GlcNAc...) Ref.8 | ||||||||
| Disulfide bond | 170 ↔ 193 | By similarity | |||||||||
| Disulfide bond | 355 ↔ 381 | By similarity | |||||||||
Natural variations | |||||||||||
| Alternative sequence | 1 – 1666 | 1666 | Missing in isoform 2. | VSP_015656 | |||||||
| Alternative sequence | 1657 – 1694 | 38 | NAGNI…DLAAT → RASLLSHHTDPNLTSGGCQL EHPPHWQLASLDPVPAQG in isoform 3. | VSP_015657 | |||||||
| Alternative sequence | 1695 – 2327 | 633 | Missing in isoform 3. | VSP_015658 | |||||||
Experimental info | |||||||||||
| Mutagenesis | 2324 | 1 | Q → G: No effect on interaction with GRIP1 and GRIP2. Ref.1 | ||||||||
| Mutagenesis | 2325 | 1 | Y → F: No effect on interaction with GRIP1 and GRIP2. Ref.1 | ||||||||
| Mutagenesis | 2325 | 1 | Y → G: Loss of interaction with GRIP1 and GRIP2. Ref.1 | ||||||||
| Mutagenesis | 2326 | 1 | W → G: Loss of interaction with GRIP1 and GRIP2. Ref.1 | ||||||||
| Mutagenesis | 2327 | 1 | V → G: Loss of interaction with GRIP1 and GRIP2. Ref.1 | ||||||||
| Sequence conflict | 1058 | 1 | D → V in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 1113 | 1 | S → P in BAD90326. Ref.5 | ||||||||
| Sequence conflict | 1427 | 1 | W → R in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 1520 | 1 | Q → E in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 1546 | 1 | S → G in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 1929 | 1 | G → E in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 2000 | 1 | Q → R in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 2011 | 1 | D → H in BAC26150. Ref.2 | ||||||||
| Sequence conflict | 2093 | 1 | G → E in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 2248 | 1 | L → H in AAL37505. Ref.1 | ||||||||
| Sequence conflict | 2300 | 1 | P → S in AAL37505. Ref.1 | ||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling." Stegmueller J., Werner H., Nave K.-A., Trotter J. J. Biol. Chem. 278:3590-3598(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH GRIP1; GRIP2 AND GRIA2, MUTAGENESIS OF GLN-2324; TYR-2325; TRP-2326 AND VAL-2327, DOMAIN, SUBCELLULAR LOCATION. Tissue: Oligodendrocyte. |
| [2] | "The transcriptional landscape of the mammalian genome." Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J. Hayashizaki Y.Science 309:1559-1563(2005) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Strain: C57BL/6J. Tissue: Embryo and Skin. |
| [3] | "Lineage-specific biology revealed by a finished genome assembly of the mouse." Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S. Ponting C.P.PLoS Biol. 7:E1000112-E1000112(2009) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. Strain: C57BL/6J. |
| [4] | Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C. Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "Prediction of the coding sequences of mouse homologues of KIAA gene. The complete nucleotide sequences of mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries." Okazaki N., Kikuno R.F., Ohara R., Inamoto S., Nagase T., Ohara O., Koga H. Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 999-2327 (ISOFORM 3). Tissue: Fetal brain. |
| [6] | "PDGF (alpha)-receptor is unresponsive to PDGF-AA in aortic smooth muscle cells from the NG2 knockout mouse." Grako K.A., Ochiya T., Barritt D., Nishiyama A., Stallcup W.B. J. Cell Sci. 112:905-915(1999) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, DISRUPTION PHENOTYPE. |
| [7] | "NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin." Fukushi J., Makagiansar I.T., Stallcup W.B. Mol. Biol. Cell 15:3580-3590(2004) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY, FUNCTION. |
| [8] | "The mouse C2C12 myoblast cell surface N-linked glycoproteome: identification, glycosite occupancy, and membrane orientation." Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I., Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E., Wollscheid B. Mol. Cell. Proteomics 8:2555-2569(2009) [PubMed] [Europe PMC] [Abstract] Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-130; ASN-1369; ASN-1454; ASN-2021 AND ASN-2080, MASS SPECTROMETRY. Tissue: Myoblast. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF352400 mRNA. Translation: AAL37505.1. AK028844 mRNA. Translation: BAC26150.1. Sequence problems. AK075625 mRNA. Translation: BAC35866.1. AC126257 Genomic DNA. No translation available. CH466522 Genomic DNA. Translation: EDL25876.1. AK220559 mRNA. Translation: BAD90326.1. |
| IPI | IPI00128915. IPI00554856. IPI00648223. |
| RefSeq | NP_620570.2. NM_139001.2. |
| UniGene | Mm.41329. |
3D structure databases | |
| ProteinModelPortal | Q8VHY0. |
| ModBase | Search... |
Protein-protein interaction databases | |
| MINT | MINT-1787512. |
PTM databases | |
| PhosphoSite | Q8VHY0. |
Proteomic databases | |
| PaxDb | Q8VHY0. |
| PRIDE | Q8VHY0. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENSMUST00000035661; ENSMUSP00000038909; ENSMUSG00000032911. |
| GeneID | 121021. |
| KEGG | mmu:121021. |
| UCSC | uc009ptl.1. mouse. |
Organism-specific databases | |
| CTD | 1464. |
| MGI | MGI:2153093. Cspg4. |
| Rouge | Search... |
Phylogenomic databases | |
| eggNOG | NOG261397. |
| GeneTree | ENSGT00550000074429. |
| HOGENOM | HOG000170195. |
| HOVERGEN | HBG081360. |
| InParanoid | Q8VHY0. |
| KO | K08115. |
| OMA | RPIYRFT. |
| OrthoDB | EOG42BX7N. |
Gene expression databases | |
| CleanEx | MM_CSPG4. |
| Genevestigator | Q8VHY0. |
| GermOnline | ENSMUSG00000032911. Mus musculus. |
Family and domain databases | |
| Gene3D | 2.60.120.200. 2 hits. |
| InterPro | IPR008985. ConA-like_lec_gl_sf. IPR013320. ConA-like_subgrp. IPR027210. Cspg4. IPR001791. Laminin_G. [Graphical view] |
| PANTHER | PTHR32539:SF0. PTHR32539:SF0. 1 hit. |
| Pfam | PF00054. Laminin_G_1. 1 hit. PF02210. Laminin_G_2. 1 hit. [Graphical view] |
| SMART | SM00282. LamG. 2 hits. [Graphical view] |
| SUPFAM | SSF49899. ConA_like_lec_gl. 2 hits. |
| PROSITE | PS50025. LAM_G_DOMAIN. 2 hits. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 369752. |
| SOURCE | Search... |
Entry information
| Entry name | CSPG4_MOUSE | ||||||||
| Accession | Primary (citable) accession number: Q8VHY0 Secondary accession number(s): G5E892 Q8CE79 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
Relevant documents
| MGD cross-references Mouse Genome Database (MGD) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
